Acute Porphyria Drug Database

Monograph

V03AC01 - Deferoxamine
Not porphyrinogenic
NP

Rationale
Not metabolised, excreted unchanged in iron-associated form.
Chemical description
Water soluble aliphatic iron-complexing compound used in treatment of iron poisoning and hemochromatosis. Mainly metabolized to a glucuronide conjugate which is excreted.

Similar drugs
Explore alternative drugs in similar therapeutic classes V03A / V03AC or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Desferal · Desferal, poeder voor oplossing voor injectie of infusie 500 mg
Belgium
Desferal · Desferal 500 mg sol. inj. (pdr.) s.c./i.v./i.m. flac.
United Kingdom
Desferal · Desferal 2g powder for solution for injection vials · Desferal 500mg powder for solution for injection vials · Desferrioxamine · Desferrioxamine 2g powder for solution for injection vials · Desferrioxamine 500mg powder for solution for injection vials
Denmark
Deferoxaminmesilat · Deferoxaminmesilat "Orifarm" · Desferal
Norway
Desferal
Poland
Desferal
Luxembourg
DESFERAL
Iceland
Desferal
Finland
Desferal
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙